Biohit HealthCare signs distribution contract with Euro Diagnostica

Biohit Oyj Stock exchange release 28.5.2012 at 15.30 

Finnish health care company Biohit Plc. signed a distribution contract on Thursday May 24th with EuroDiagnostica an International diagnostics company, based in Malmö, Sweden . 

Euro Diagnostica will exclusively distribute and market Biohit’s biomarker test, GastroPanel, in Sweden, Norway and Denmark. The company singed also a non-exclusive distribution agreement for Germany, Switzerland and the Netherlands.  GastroPanel examinations diagnose diseases of the stomach and the risks associated with these diseases. Wieslab laboratories will also include GastroPanel into the product offering in Sweden and in the Netherlands.

‘’We are looking forward very much to the collaboration with Biohit as the company’s portfolio complements Euro Diagnostica’s line of business,’’ says Else Beth Trautner
the CEO of Euro Diagnostica.

Biohit’s CEO Semi Korpela is also pleased with the contract. ‘’ I believe this is a perfect match and together we have all the chances to make this cooperation a very fruitful one’’.

Biohit HealthCare in brief
Biohit HealthCare is a globally operating biotechnology company that develops, manufactures and markets diagnostic tests and analysis systems.

EuroDiagnostica in brief
Euro Diagnostica is a full service diagnostic solutions company. During the last two decades, its world class scientists have been the first to develop and produce top quality ELISA kits for ANCA, anti-CCP, Complement and Chromogranin A assays which are now in use all over the world.

Additional information:

Biohit Plc.
Semi Korpela, CEO
Tel. +358 9 773 86 333
semi.korpela@biohit.fi

EuroDiagnostica
Else Beth Trautner, CEO
Tel    +46 40 53 76 85
ElseBeth.Trautner@eurodiagnostica.com